Scarica l'app Stockscreener
14.73
2.79%
0.40
Dopo l'orario di chiusura:
14.70
-0.03
-0.20%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Perché MED Giù?
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$14.33
Aprire:
$14.52
Volume 24 ore:
328.00K
Relative Volume:
1.41
Capitalizzazione di mercato:
$161.11M
Reddito:
$1.07B
Utile/perdita netta:
$99.41M
Rapporto P/E:
1.6258
EPS:
9.06
Flusso di cassa netto:
$141.17M
1 W Prestazione:
-9.13%
1M Prestazione:
-6.42%
6M Prestazione:
-24.27%
1 anno Prestazione:
-63.52%
Intervallo 1D:
$14.24
$14.94
Intervallo di 1 settimana:
$13.57
$16.45
Portata 52W:
$13.57
$42.68
Medifast Inc Stock (MED) Company Profile
Nome
Medifast Inc
Settore
Industria
Telefono
(732) 764-0619
Indirizzo
11445 CRONHILL DRIVE, OWINGS MILLS, MD
Confronta MED con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MED
Medifast Inc
|
14.73 | 161.11M | 1.07B | 99.41M | 141.17M | 9.06 |
|
ROL
Rollins Inc
|
51.29 | 24.84B | 3.31B | 469.51M | 537.75M | 0.96 |
|
SCI
Service Corp International
|
78.91 | 11.38B | 4.15B | 505.69M | 587.50M | 3.44 |
|
BFAM
Bright Horizons Family Solutions Inc
|
126.39 | 7.35B | 2.63B | 116.59M | 215.93M | 1.99 |
|
HRB
H R Block Inc
|
52.27 | 7.00B | 3.62B | 586.22M | 657.77M | 4.10 |
|
FTDR
Frontdoor Inc
|
57.10 | 4.33B | 1.83B | 234.00M | 235.00M | 3.03 |
Medifast Inc Stock (MED) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-05 | Aggiornamento | DA Davidson | Underperform → Neutral |
| 2024-06-05 | Downgrade | DA Davidson | Neutral → Underperform |
| 2023-10-13 | Iniziato | Stephens | Equal-Weight |
| 2022-11-04 | Downgrade | DA Davidson | Buy → Neutral |
| 2022-08-04 | Downgrade | Jefferies | Buy → Hold |
| 2021-01-25 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-11-05 | Aggiornamento | DA Davidson | Neutral → Buy |
| 2020-06-25 | Iniziato | B. Riley FBR | Buy |
| 2020-02-27 | Downgrade | Jefferies | Buy → Hold |
| 2019-11-08 | Downgrade | Dougherty & Company | Buy → Neutral |
| 2019-07-25 | Iniziato | Jefferies | Buy |
| 2018-11-08 | Aggiornamento | Sidoti | Neutral → Buy |
| 2018-03-07 | Aggiornamento | Sidoti | Neutral → Buy |
| 2017-09-15 | Reiterato | DA Davidson | Buy |
| 2016-08-04 | Reiterato | Wunderlich | Hold |
| 2016-01-11 | Aggiornamento | Sidoti | Neutral → Buy |
| 2015-11-30 | Downgrade | Sidoti | Buy → Neutral |
| 2015-10-05 | Aggiornamento | Sidoti | Neutral → Buy |
| 2014-11-07 | Downgrade | Imperial Capital | Outperform → In-line |
| 2014-08-08 | Reiterato | Imperial Capital | Outperform |
| 2014-04-23 | Reiterato | Imperial Capital | Outperform |
| 2013-09-06 | Iniziato | Imperial Capital | Outperform |
| 2012-11-06 | Reiterato | Northland Securities | Outperform |
| 2012-07-27 | Aggiornamento | Northland Securities | Market Perform → Outperform |
| 2012-07-09 | Downgrade | Standpoint Research | Buy → Hold |
| 2012-01-30 | Iniziato | Standpoint Research | Buy |
Mostra tutto
Medifast Inc Borsa (MED) Ultime notizie
Institutional owners may take dramatic actions as Medifast, Inc.'s (NYSE:MED) recent 11% drop adds to one-year losses - Simply Wall St
MED Q4 Earnings Beat, Revenues Dip Y/Y on Lower Customer Acquisition - MSN
Medifast stock target cut to $16.50 by DA Davidson - Investing.com UK
Medifast (MED) PT Lowered to $16.50 at DA Davidson - StreetInsider.com
Medifast Reports Financial Results for Q4 and Full Year 2024 - Direct Selling News
Medifast stock hits 52-week low at $14.76 amid sharp decline - Investing.com
Medifast, Inc. (NYSE:MED) Q4 2024 Earnings Call Transcript - MSN
Medifast Beats Revenue Expectations Amidst Sharp Sales DeclineNews and Statistics - IndexBox, Inc.
Medifast: Q4 Earnings Snapshot - mySA
Medifast Inc (MED) Q4 2024 Earnings Call Highlights: Navigating Challenges with Strategic ... By GuruFocus - Investing.com Canada
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Medifast, Inc. and Encourages Investors to Contact the Firm - ACCESS Newswire
Medifast outlines 2025 priorities with plans for $15M-$20M cost savings and new product expansions - MSN
Medifast (MED) Q4 Earnings Report Preview: What To Look For - MSN
Earnings call transcript: Medifast Q4 2024 beats EPS, misses revenue - Investing.com
Medifast (MED) Q4 Earnings and Revenues Beat Estimates - Yahoo Finance
Medifast Inc reports results for the quarter ended December 31Earnings Summary - TradingView
MEDIFAST INC SEC 10-K Report - TradingView
Medifast (NYSE:MED) Surprises With Q4 Sales But Quarterly Revenue Guidance Significantly Misses Expectations - Investing.com Canada
Medifast Q4 Earnings Reveal Sharp Revenue Drop Despite $162M Cash Cushion - StockTitan
Medifast stock hits 52-week low at $14.88 amid sharp decline - Investing.com Nigeria
Medifast (MED) Q4 Earnings Report Preview: What To Look For By Stock Story - Investing.com Canada
What Is Medifast, Inc.'s (NYSE:MED) Share Price Doing? - Yahoo Finance
Medifast (MED) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Medifast, Inc. (MED) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire
Medifast stock hits 52-week low at $14.88 amid sharp decline By Investing.com - Investing.com South Africa
Medifast, Inc. to Host Earnings Call - ACCESS Newswire
Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Business Wire
Medifast Earnings Alert: Key Financial Results Coming February 18What's at Stake for OPTAVIA - StockTitan
JPMorgan Chase & Co. Increases Position in Medifast, Inc. (NYSE:MED) - MarketBeat
MED Focused on GLP-1 Solutions Amid Customer Acquisition Challenges - MSN
Medifast: Strong Balance Sheet, But I Lack Conviction In The Turnaround (NYSE:MED) - Seeking Alpha
Medifast stock hits 52-week low at $15.09 amid sharp decline - MSN
Weight Loss Diet Products Market Projected To Witness Substantial Growth, 2024-2031|VLCC Healthcare Ltd, - EIN News
Medifast Launches OPTAVIA ASCEND for Weight Loss Management - MSN
An Intrinsic Calculation For Medifast, Inc. (NYSE:MED) Suggests It's 41% Undervalued - Simply Wall St
Medifast Introduces New High-Protein Product Line OPTAVIA ASCEND™ For GLP-1 Users & Those Looking for Help to Keep Weight Off - Marketscreener.com
Medifast Introduces New High-Protein Product Line OPTAVIA ASCEND™ For GLP-1 Users & Those Looking for Help to Keep Weight Off – Company AnnouncementFT.com - Financial Times
Medifast Launches OPTAVIA ASCEND: High-Protein Line Targets GLP-1 Weight Management Challenge - StockTitan
Medifast stock hits 52-week low at $16.7 amid sharp decline - Investing.com Nigeria
Medifast, Inc. (NYSE:MED) Stock Holdings Decreased by Geode Capital Management LLC - MarketBeat
Medifast Inc Azioni (MED) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.29%
0.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):